| Prevalence of psychoactive substance use Prevalence of medication use Prevalence of drug use Drug prevention Treatment supply Treatment demand Health consequences Harm reduction Drug-related crimes Drug market Drug use and prison Monitoring of publications Attitudes to legal framework changes |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2023
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| Total number of PWID who were tested | 203 | 203 | 204 |
| Males | 145 | 144 | 145 |
| Females | 58 | 59 | 59 |
| Number of PWID with a positive test result | 32 | 30 | 175 |
| Males | 29 | 25 | 129 |
| Females | 3 | 5 | 46 |
| Proportion positive (%) | 15.8% | 14.8% | 85.8% |
| Males | 20.0% | 17.4% | 89.0% |
| Females | 5.2% | 8.5% | 78.0% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2023 (by age groups)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| Age <25 | |||
| Number of PWID who were tested | 2 | 2 | 2 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% |
| Age 25-34 | |||
| Number of PWID who were tested | 16 | 16 | 16 |
| Number of PWID with a positive test result | 3 | 4 | 14 |
| Proportion positive (%) | 18.75% | 25.0% | 87.5% |
| Age > 34 | |||
| Number of PWID who were tested | 185 | 185 | 186 |
| Number of PWID with a positive test result | 29 | 26 | 161 |
| Proportion positive (%) | 15.7% | 14.1% | 86.6% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2023 (by years since first injection)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| <2 years since first injection | |||
| Number of PWID who were tested | 1 | 1 | 1 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% |
| 2 to 4 years since first injection | |||
| Number of PWID who were tested | 1 | 1 | 1 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% |
| 5 to 9 years since first injection | |||
| Number of PWID who were tested | 7 | 7 | 7 |
| Number of PWID with a positive test result | 1 | 1 | 2 |
| Proportion positive (%) | 14.3% | 14.3% | 28.6% |
| 10 or more years since first injection | |||
| Number of PWID who were tested | 194 | 194 | 195 |
| Number of PWID with a positive test result | 31 | 29 | 173 |
| Proportion positive (%) | 16.0% | 14.9% | 88.7% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2023 (by primary drug)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| PWID with primary drug opioids | |||
| Number of PWID who were tested | 189 | 189 | 190 |
| Number of PWID with a positive test result | 32 | 27 | 175 |
| Proportion positive (%) | 16.9% | 14.3% | 92.1% |
| PWID with primary drug cocaine | |||
| Number of PWID who were tested | 3 | 3 | 3 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% |
| PWID with primary drug stimulants other than cocaine | |||
| Number of PWID who were tested | 7 | 7 | 7 |
| Number of PWID with a positive test result | 0 | 3 | 0 |
| Proportion positive (%) | 0.0% | 42.9% | 0.0% |
| PWID with primary drug other | |||
| Number of PWID who were tested | 4 | 4 | 4 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2023 (by contact with drug treatment in the last 12 months)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| PWID who have been in contact with drug treatment services in the last 12 months | |||
| Number of PWID who were tested | 176 | 176 | 177 |
| Number of PWID with a positive test result | 32 | 25 | 165 |
| Proportion positive (%) | 18.2% | 14.2% | 93.2% |
| PWID who have not been in contact with drug treatment services in the last 12 months | |||
| Number of PWID who were tested | 26 | 26 | 26 |
| Number of PWID with a positive test result | 0 | 5 | 10 |
| Proportion positive (%) | 0.0% | 19.2% | 38.5% |
| PWID with missing information on drug treatment contact | |||
| Number of PWID who were tested | 1 | 1 | 1 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2023 (by imprisonment)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| PWID ever in prison | |||
| Number of PWID who were tested | 21 | 21 | 21 |
| Number of PWID with a positive test result | 7 | 7 | 19 |
| Proportion positive (%) | 33.3% | 33.3% | 90.5% |
| PWID never in prison | |||
| Number of PWID who were tested | 182 | 182 | 183 |
| Number of PWID with a positive test result | 25 | 23 | 156 |
| Proportion positive (%) | 13.7% | 12.6% | 85.2% |
Source: State Psychiatric Hospital for Treatment of Drug Addiction and Alcoholism (SPHTDAA), Sofia, NFP, NCPHA.